Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Current Assets (2020 - 2025)

NeuroPace has reported Current Assets over the past 6 years, most recently at $94.1 million for Q4 2025.

  • Quarterly results put Current Assets at $94.1 million for Q4 2025, up 15.66% from a year ago — trailing twelve months through Dec 2025 was $94.1 million (up 15.66% YoY), and the annual figure for FY2025 was $94.1 million, up 15.66%.
  • Current Assets for Q4 2025 was $94.1 million at NeuroPace, down from $95.3 million in the prior quarter.
  • Over the last five years, Current Assets for NPCE hit a ceiling of $146.4 million in Q2 2021 and a floor of $47.1 million in Q1 2021.
  • Median Current Assets over the past 5 years was $93.9 million (2025), compared with a mean of $98.3 million.
  • Peak annual rise in Current Assets hit 159.98% in 2022, while the deepest fall reached 26.43% in 2022.
  • NeuroPace's Current Assets stood at $132.8 million in 2021, then decreased by 26.43% to $97.7 million in 2022, then decreased by 5.11% to $92.7 million in 2023, then fell by 12.27% to $81.3 million in 2024, then grew by 15.66% to $94.1 million in 2025.
  • The last three reported values for Current Assets were $94.1 million (Q4 2025), $95.3 million (Q3 2025), and $93.7 million (Q2 2025) per Business Quant data.